Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)

Share

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) (via PR Newswire)

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the…

Click for a printer friendly version

Back to top